PPCB is Propanc Biopharma, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $1.03. Market cap: $3M.
Stock snapshot
| Price | $1.03 |
| Market cap | $3M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About PPCB
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Related non-dividend companies
Other non-dividend stocks investors research alongside PPCB. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is PPCB's current stock price?
PPCB (Propanc Biopharma, Inc.) is currently trading at $1.03.
Does PPCB pay a dividend?
PPCB (Propanc Biopharma, Inc.) does not currently pay a regular dividend.
Track PPCB in DiviDrip
Add PPCB to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search PPCB and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.